Infectious pancreatic necrosis virus (IPNV), a member of the Birnaviridae with two double-stranded RNA genome segments, encodes five proteins designated VP1 to VP5. To study the function of the 17 kDa nonstructural protein VP5 during virus replication several mutated IPNV genome segments A were constructed and included in a reverse genetics system for IPNV to obtain recombinant virus. Mutations between nt 68 and 85 or nt 94 and 103 in the noncoding region failed to yield viable virus. Only mutations located between nt 86 and 92 and downstream of nt 104 were tolerated, and viable virus could be generated. All IPNV generated showed no difference in replication compared with the wild-type IPNV, indicating that the absence of expression of VP5 did not influence virus growth in vitro. Furthermore, the results presented here indicate that initiation of translation of VP5 occurs at position 113, the second in-frame start codon.
Introduction
Infectious pancreatic necrosis virus (IPNV) was first isolated in North America in 1960 as the aetiological agent of an acute, highly contagious disease of juvenile rainbow and brook trout (Wolf, 1988) . More recently, significant outbreaks associated with IPNV occurred in Norwegian and Scottish marine farmed Atlantic salmon (Jarp et al., 1994) and in farmed halibut in the United Kingdom (Rodger & Frerichs, 1997) . Salmonids under 6 months of age are commonly infected. Furthermore, IPNV has been isolated from other species including pike, carp and several marine farmed fish (Castric, 1997) . IPNV can be divided into two serogroups (A and B). Nine different serotypes have been distinguished so far in serogroup A, whereas serogroup B contains only one serotype (Hill & Way, 1995) .
IPNV belongs to the genus Aquabirnavirus, family Birnaviridae (Leong et al., 2000) . The genome consists of two segments, A and B, of double-stranded (ds) RNA, which are localized within a single-shelled icosahedral capsid 60 nm in diameter. The larger segment, A, encodes a polyprotein of approximately 106 kDa which is autoproteolytically cleaved to form the viral capsid proteins (VP) VP2 and VP3, and a nonstructural (NS) protein (Duncan & Dobos, 1986 ; Duncan et al., 1987) . Recently, the active residues in the NS protein Author for correspondence : Egbert Mundt.
Fax j49 38351 7151. e-mail Egbert. Mundt!rie.bfav.de responsible for processing of the polyprotein have been identified, thus proving that NS represents the viral protease (Birghan et al., 2000 ; Petit et al., 2000) . The cleavage sites of the polyprotein have also been determined (Petit et al., 2000) . A 17 kDa protein encoded by a second open reading frame (ORF) which precedes and partially overlaps the polyprotein gene has been detected in virus-infected cells (Magyar & Dobos, 1994) . This protein has been designated VP5, according to its positional homologue in infectious bursal disease virus (IBDV ; . Genome segment B encodes a 94 kDa protein, designated VP1, which represents the putative viral RNA-dependent RNA polymerase (Duncan et al., 1991) . For a review on the molecular biology of IPNV see Dobos (1995) .
Reverse genetics has become an important tool for analysing the molecular biology of RNA viruses, for the development of novel vaccines, and for constructing vectors for gene therapy (Conzelmann & Meyers, 1996) . For the Birnaviridae two reverse genetics systems have been described. Using synthetic cRNA transcripts of plasmid-cloned fulllength segments A and B of IBDV, which affects young chickens, Mundt & Vakharia (1996) described the recovery of infectious virus. The second system was described recently for IPNV (Yao & Vakharia, 1998) . Thus, the basis has been provided for more detailed analysis of birnavirus replication. We were interested in the influence on virus replication of the small nonstructural protein VP5 encoded in segment A of IPNV. Furthermore, there are conflicting reports about the initiation of expression of VP5. Heppell et al. (1995) detected several initiation sites for the expression of VP5 dependent on the virus strain. Another report suggested that the initiation codon of VP5 was at position 68 located in the 5h-noncoding region (NCR) of segment A (Duncan & Dobos, 1995) . However, sequence analysis of strain West Buxton suggested that VP5 is initiated at position 112 (Yao & Vakharia, 1998) . We analysed the initiation of VP5 expression and the consequences of mutations of VP5 on IPNV replication in cell culture.
Methods
Cells, virus and sera. Chinook salmon embryonic (CHSE-214) cells (Collection of cell lines in veterinary medicine, Insel Riems ; RIE 341) were grown at 15 mC in minimal essential medium (MEM) supplemented with 10 % foetal calf serum (FCS) and used for propagation of virus, transfection experiments and immunofluorescence assays. IPNV strain VR299 (provided by Professor G. Witzigmann, Grub, Germany) was used for the experiments.
The polyclonal rabbit anti-IPNV serum was a generous gift from Dr Rijke (Intervet, Boxmeer, The Netherlands). To obtain a specific polyclonal anti-VP5 serum a peptide comprising 15 amino acids of VP5 (LRETDLTEIRHPELN, amino acids 97-111) was used for repeated immunization of a rabbit (Mollegard, Ejby, Denmark). Sera were used for immunofluorescence assays and Western blot.
Determination of viral sequences. IPNV strain VR299 was propagated and viral particles were purified as described (Mu$ ller et al., 1986) . Pelleted viral particles were incubated overnight with proteinase K (0n5 mg\ml) and SDS (0n5%) at 37 mC. The genomic viral dsRNA was extracted with phenol-chloroform, recovered by ethanol precipitation, and used for amplification of viral cDNA. The extreme ends of both segments were sequenced by using two methods, poly(A) tailing (Cashdollar et al., 1982) and 5h-RACE (Frohman et al., 1988) , as described . IPNV-specific oligonucleotides (Table 1) (Duncan et al., 1987 (Duncan et al., , 1991 . The PCR fragments obtained were cloned blunt-ended into SmaI-cleaved pUC18 (Pharmacia) and appropriate clones were sequenced.
Construction of full-length cDNA clones. Based on the data obtained by determination of the terminal sequences, oligonucleotides were designed to obtain full-length clones of both segments (A and B). Following reverse transcription the full-length genome consisting of segments A and B was amplified in two pieces using Deep Vent polymerase (New England Biolabs ; see Fig. 1 ). For amplification of the 5h fragment (A5h-Frag) of segment A primer pair A5h-Aas06 was used ; for amplification of the 3h fragment (A3h-Frag) primer pair As05-A3h was used. Amplified fragments were cloned into SmaI-cleaved vector pUC18 (Pharmacia) to obtain p-A5h and p-A3h, respectively. After sequencing, one unique restriction enzyme cleavage site (BstXI) located in the overlapping region of both fragments, and a cleavage site (HindIII) located in plasmid pUC18, were used to fuse both fragments. To this end, A3h-Frag was excised with BstXI\HindIII and ligated into BstXI\HindIII-cleaved p-A5h to obtain full-length segment A (pFKA299) under control of the T7 promotor. For construction of a full-length clone of segment B primer pair B5h-Bas06 was used for amplification of the 5h fragment of segment B ; the 3h fragment of segment B was amplified with primer pair Bs05-B3h. Both fragments were cloned blunt-ended to obtain p-B5h and p-B3h, respectively. After sequencing, a unique cleavage site (PmlI) located in the overlapping region of both fragments was used together with the HindIII cleavage site located in the vector to ligate the B3h fragment into the PmlI\HindIII-cleaved p-B5h. The resulting plasmid, pFKB299, contained the full-length segment B under control of the T7 promotor. Oligonucleotides used are listed in Table 1 ; pFKA299 and pFKB299 are depicted in Fig. 1 .
Site-directed mutagenesis. Mutations were introduced into the segment A cDNA of strain VR299 by two methods. (i) For introduction of a tag-sequence an additional BamHI site was created by silent mutations. To this end, PCR fragments were amplified from pFKA299 using primer pairs BamF-Aas3 and BamR-As5 (Table 1) , and cloned blunt-ended to obtain pBamF and pBamR, respectively. Plasmids were Restriction enzymes and their cleavage sites used for cloning are indicated. Full-length cDNAs were constructed under control of the T7 RNA polymerase promoter. Sequences of oligonucleotides (Primer) used for site-directed mutagenesis of VP5 and names of the resulting plasmids are shown. Dashes mark residues identical to the sequence of strain VR299 and altered nucleotides are indicated. Generated viable virus is marked by ' j ' and nonviable virus by ' k '. Numbering of nucleotides is according to the published sequence of segments A and B of strain Jasper (accession nos M18049, M58756).
sequenced and an appropriate clone of pBamF was cleaved by BamHI and ligated into BamHI-cleaved pBamR to obtain pBam-tag. The mutated sequence was confirmed by sequencing. pBam-tag was cleaved with StuI\NcoI and the eluted fragment was subsequently ligated into appropriately cleaved pFKA299. The plasmid obtained, pFKA299-tag, thus contains a sequence tag in the NS coding region of segment A.
(ii) For analysis of initiation of VP5 expression site-directed mutagenesis was performed following the protocol described by Kunkel et al. (1987) . To this end a SmaI-KpnI fragment of pFKA299 containing the fulllength viral sequence was subcloned into appropriately cleaved plasmid pBluescript II SK(k) to obtain pSK-A299. After site-directed mutagenesis with oligonucleotides ( Fig. 1 ) suitable mutated plasmids were selected by sequencing, cleaved with BspEI\KpnI, and fragments were ligated into appropriately cleaved pFKA299. Plasmids obtained (Fig. 1) were used for transfection experiments.
Virus recovery from cRNA in tissue culture. For in vitro transcription, plasmids containing the various segments A (Fig. 1 ) and pFKB299 were linearized by cleavage with either SmaI or PstI, respectively. Further treatment of linearized DNA and transcription were carried out as described by Mundt & Vakharia (1996) , with the exception that the transcription mixtures were not purified by phenol-chloroform extraction. CHSE-214 cells grown to 90 % confluency in tissue culture flasks were transfected with cRNA of both segments as described by Mundt & Vakharia (1996) . Cells were incubated at 15 mC. Parallel cell cultures were either freeze-thawed and supernatants were passaged onto CHSE-214 cells, or they were fixed with acetone-methanol (1 : 1) and processed for indirect immunofluorescence using a polyclonal rabbit anti-IPNV serum.
Characterization of virus replication in cell culture.
To compare replication of wild-type IPNV (VR299) with IPNV generated by reverse genetics, growth kinetics were established. Confluent CHSE-214 cells were infected with VR299, VR299Rev, VR299Mut7, VR299Mut8, VR299Mut9, VR299Mut11, VR299Mut14, VR299Mut15, VR299-Mut16Stop, VR299Mut16Ala or VR299Mut16Leu at an m.o.i. of 1. Following incubation at 15 mC for 1 h, the inoculum was removed, cells were rinsed twice with PBS, and overlaid with 2n5 ml MEM containing 10 % FCS. Immediately thereafter one flask was removed and stored at k70 mC [0 h post-infection (p.i.)]. Remaining flasks were incubated further. At 5, 10, 15, 20, 25, 30, 35, 40 and 45 h p.i. flasks were removed and stored at k70 mC. Supernatants were centrifuged and titrated on CHSE-214 cells.
To analyse viral protein synthesis CHSE-214 cells grown in a 12n5 cm# tissue culture flask were infected with the wild-type VR299 or the recombinant IPNV at an m.o.i. of 1. Cells were incubated at 15 mC S. Weber and others S. Weber and others until 20 h p.i., scraped off the flask and sedimented. The pellets obtained were resuspended in 50 µl PBS, lysed in 50 µl electrophoresis buffer (50 mM Tris-HCl pH 6n8, 20 % glycerol, 4 % SDS, 10 % 2-mercaptoethanol), boiled for 2 min, and centrifuged at 13 000 g for 2 min. The supernatants were subjected to SDS-PAGE ; separated proteins were then electrophoretically transferred to nitrocellulose and probed with the anti-IPNV serum and an anti-VP5 serum. Bound antibodies were visualized by subsequent incubation with horseradish peroxidaseconjugated anti-rabbit immunoglobulins (Sigma), and detected by chemiluminescence (ECL, Amersham) recorded on X-ray films.
Identification of recombinant IPNV by RT-PCR. CHSE-214 cells grown in two 75 cm# tissue culture flasks were infected with the recombinant VR299 viruses at an m.o.i. of 0n1. Five days after infection cells were freeze-thawed and the supernatants were clarified by lowspeed centrifugation. Virus particles contained in the supernatants were sedimented by ultracentrifugation [28000 r.p.m., 1 h, SW 28 rotor (Beckman)]. The pellets were resuspended in PBS containing proteinase K (1 mg\ml) and SDS (0n5 %), and the dsRNA was recovered as described . RT-PCR was performed using the protocol established for IBDV . Appropriate PCR fragments were cloned blunt-ended and sequenced.
Results

Sequence determination of the IPNV genome
To establish a reverse genetics system the complete genomic sequence of IPNV strain VR299 was determined. Genome segment A of VR299 comprises 3097 bp and contains two overlapping reading frames encoding the VP2-3-4 polyprotein and VP5. Segment B contains 2783 bp with one ORF encoding a 94 kDa protein (VP1), the putative RNAdependent RNA polymerase. The full-length nucleotide and amino acid sequences were compared with full-length sequences of segments A and B of strains West Buxton (GenBank accession nos AF078668, AF078669) and Jasper (M18049, M58756). Nucleotide and deduced amino acid sequences of strain Jasper segment A were 99n7 % identical to VR299. In contrast, the nucleotide sequence of segment A of strain West Buxton was only 94n2 % identical to VR299, whereas amino acid identity amounted to 97n2 % due to genetic code degeneration. For segment B of both strains the IAI identities at the nucleotide (strain Jasper 90n1 %, strain West Buxton 91n5 %) and amino acid levels (strain Jasper 97n4%, strain West Buxton 97n9 %) were similar. For determination of the sequence of the extreme ends of both segments five independent clones obtained by each method [5h-RACE and poly(A) tailing] representing the longest sequence of each terminus were sequenced, and analysed using the GCG computer program (Genetics Computer Group, Madison, WI, USA). Comparison with terminal sequences of segments A of strains Jasper (M18049) and West Buxton (AF078668) shows high identity (Fig. 2) . However, in the 5h-terminal sequence of segment A of strain West Buxton a deletion at nt 105 resulted in a frameshift in the ORF encoding VP5 as compared with the sequences of strains Jasper and VR299, respectively. Furthermore, an additional nucleotide at the extreme 3h-end of segment A of strain West Buxton as described by Yao & Vakharia (1998) was not present in VR299. Comparison of the terminal sequences of segment B with sequences of strains Jasper (M58756) and West Buxton (AF078669) revealed near identity at the 5h-end. In contrast, more nucleotide substitutions were detected in the 3h-terminal sequences. Here, an additional nucleotide at position 2644 as described for strain Jasper (Duncan et al., 1991) could not be found.
Comparison with the partial sequences of segment A of strain VR299 published earlier (Heppell et al., 1995) revealed 100 % identity in the 5h-NCR and three nucleotide substitutions in the coding region of the polyprotein. One of them was silent (nt 662) and two resulted in amino acid substitutions (VR299Hep Arg#!$ to Lys VR299 ; VR299Hep Thr#$( to Ala VR299). The sequence encoding VP5 was identical.
Rescue of IPNV from cDNA
For transfection, full-length cDNA clones of segments A (pFKA299) and B (pFKB299) of strain VR299 were transcribed into synthetic cRNA and cotransfected into CHSE-214 cells. Viral antigen was first detected 4 days post-transfection (p.t.) by immunofluorescence using rabbit anti-IPNV serum (data not shown). A titre of 10# n * TCID &! \ml was determined in supernatants of transfected cells after freeze-thawing at 4 days p.t. At 5 days p.t. a CPE was noticed and the titre in the supernatant rose to 10%
n & TCID &! \ml. CPE and titres increased until 8 days p.t. At that time cells were nearly completely lysed and the titre in the supernatant reached 10)
n & TCID &! \ml. To prove that the generated virus was indeed recovered from cRNA, pFKA299 and pFKA299-tag were cotransfected with cRNA of pFKB299 into CHSE-214 cells to obtain VR299Rev and VR299-tag, respectively. At day 6 p.t. cells were freeze-thawed and the supernatant was passaged twice. Viral genomic RNA was isolated, amplified with a primer pair encompassing the mutated region in NS of IPNV, and the resulting fragment was incubated with BamHI (Fig. 3) . As expected, the 626 bp fragment of VR299Rev remained uncleaved, whereas the fragment of VR299-tag was cleaved into two smaller DNA fragments of 306 and 320 bp. This indicated that the recovered virus, VR299-tag, contained the engineered BamHI restriction site and, thus, resulted from the transfection experiment. No PCR product was detected in reactions where the RT step was omitted or in various controls, which also excludes contamination by DNA from the transfection experiments.
Isolation of IPNV mutants
In order to analyse the initiation site for expression of VP5 several mutations in segment A were introduced (see Fig. 1 ). After transfection of CHSE-214 cells with cRNA of pFKA299Mut1ATC, pFKA299Mut1ACG, pFKA299Mut1TTG, pFKA299Mut1CGA, pFKA299Mut2, pFKA299Mut3, pFKA299Mut4, pFKA299Mut5, pFKA299Mut6, pFKA299Mut10, pFKA299Mut11 or pFKA299Mut12 in combination with cRNA of pFKB299, infectious virus could not be isolated. Moreover, no positive immunofluorescence was detected at any time-point p.t. (1-8 days p.t.) . These experiments were repeated four times with similar negative results. However, infectious virus was recovered after transfection of cRNA obtained from plasmids pFKA299Mut7, pFKA299Mut8, pFKA299Mut9, pFKA299Mut13, pFKA299Mut14, pFKA299-Mut15, pFKA299Mut16Stop, pFKA299Mut16Ala or pFKA299Mut16Leu in combination with cRNA of segment B, resulting in recombinant IPNV VR299Mut7, VR299Mut8, S. Weber and others S. Weber and others Fig. 4 . Western blot analysis of IPNV-infected cells. CHSE-214 cells were infected with wild-type strain VR299 and recombinant VR299Mut7, VR299Mut8, VR299Mut9, VR299Mut13, VR299Mut14, VR299Mut15, VR299Mut16Stop, VR299Mut16Ala or VR299Mut16Leu. Infected cell proteins and uninfected controls were separated by SDS-PAGE. The membranes were incubated with anti-IPNV serum (A) or anti-VP5 serum (B) after electroblotting. Locations of viral proteins VP2, VP3 and VP5 are marked.
VR299Mut9, VR299Mut13, VR299Mut14, VR299Mut15, VR299Mut16Stop, VR299Mut16Ala or VR299Mut16Leu.
To analyse the expression of viral proteins in more detail and to assay for the presence of VP5, Western blots were performed using infected cell cultures of the second passage of the cDNA-derived viruses (VR299Mut7, VR299Mut8, VR299Mut9, VR299Mut13, VR299Mut14, VR299Mut15, VR299Mut16Stop, VR299Mut16Ala, VR299Mut16Leu) or the wild-type strain VR299 (Fig. 4 A, B) . The polyclonal anti-IPNV serum (Fig. 4 A) showed no differences in the molecular mass of VP2 and VP3 as expressed by the mutant VR299 in comparison to the wild-type strain VR299. The rabbit anti-VP5 serum (Fig. 4 B) recognized the 17 kDa VP5 in cells infected by VR299, VR299Rev, VR299Mut7, VR299Mut8, VR299Mut9, VR299Mut13, VR299Mut14 or VR299Mut15 but not in cells infected by VR299Mut16Stop, VR299Mut16Ala or VR299Mut16Leu. This result showed for the first time that expression of VP5 of IPNV is dispensable for virus replication.
To test the stability of the introduced mutations, recombinant virus from the second passage was analysed by RT-PCR using primers A5h and Aas10 (Table 1) . Analysis of the resulting sequences showed the continuing presence of the engineered nucleotide substitutions in the sequence of segment A (data not shown).
Characterization of IPNV mutants in CHSE-214 cells
To compare replication of recombinant IPNV (VR299Rev, VR299Mut7, VR299Mut8, VR299Mut9, VR299Mut13, VR299Mut14, VR299Mut15, VR299Mut16Stop, VR299-Mut16Ala and VR299Mut16Leu) with the wild-type strain VR299 in more detail, growth kinetics were analysed (Fig. 5 A, B) . Supernatants of infected CHSE-214 cells were removed at the indicated times p.t., and titrated on CHSE-214 cells. Titres produced by the recombinant VR299Rev were very similar to those of the wild-type strain VR299. Furthermore, neither IPNV containing mutations in the 5h-NCR of segment A (Fig. 5 A) nor IPNV deficient in expression of VP5 IBA (Fig. 5 B) showed differences compared with the wild-type VR299 at the time-points investigated.
Discussion
A reverse genetics system for IPNV was first established by Yao & Vakharia (1998) . As a first application of this approach to engineer recombinant IPNV, we describe here the generation of IPNV mutants with mutations in the 5h region of segment A.
As a prerequisite for establishment of the reverse genetics system we determined the complete sequences of both segments of IPNV strain VR299. We found one additional nucleotide in the 5h-NCR and one nucleotide less at the extreme 3h-end of segment A as compared with the West Buxton strain (Yao & Vakharia, 1998) . Since these differences obviously did not influence the generation of infectious virus, it can be inferred that these regions are somewhat variable in IPNV. These results are in accordance with Kordyban et al. (1997) who showed that the extreme ends of both segments of IPNV were variable in length. Furthermore, Boot et al. (1999) demonstrated in IBDV that a deletion of up to 8 nt at the extreme 3h-end of segment A was restored by an unknown mechanism after transfection. Thus, the extreme 3h-end of segment A can vary in length without influencing virus replication in cell culture. Variability in the length of the 3h-NCR was also shown for tick-borne encephalitis virus (Wallner et al., 1995) . However, in this virus the differences contributed to virus virulence (Mandl et al., 1998) .
The rescue of IPNV strain VR299 from cDNA was verified by detection of an artificially introduced tagged sequence in the NS coding region. The fidelity of the system was proven by comparison of IPNV rescued from cDNA (VR299Rev) with wild-type virus : this did not show any differences either concerning growth in tissue culture or in size or composition of viral proteins. As a first application of this system for functional analysis of IPNV proteins, we constructed IPNV mutants in the 5h-NCR and the VP5 ORF. Similar mutants have previously been constructed for IBDV and shown to be viable (Mundt et al., 1997 ; Yao et al., 1998) . However, mutations between nt 68 and 85 or nt 94 and 103 did not result in the recovery of progeny virus despite repeated attempts. This indicates that the alterations in this region were lethal to the virus, and that these regions apparently are critical for virus replication. Only mutations between nt 86 and 92 and downstream of nt 103 were tolerated and viable virus could be generated. Furthermore, the viable mutant viruses showed no differences in growth in cell culture compared with the wildtype virus VR299 as well as with the recombinant VR299Rev. Interestingly, the mutants which were unable to express VP5 also showed no differences compared with the wild-type virus. This contrasts with reports where IBDV VP5 mutant viruses exhibited a delay in replication and yielded lower titres compared with the wild-type virus (Mundt et al., 1997 ; Yao et al., 1998) . Thus, the absence of VP5 of IPNV had no significant influence on replication in cell culture whereas lack of VP5 of IBDV had. This might indicate either different functions of VP5 in these two viruses, or that the function of VP5 in IPNV is compensated by other mechanisms which are not present in IBDV. Also it is possible that the function of VP5 might not be expressed in the single cell line tested. Animal experiments are in progress to allow us to draw more conclusions about the function of VP5 in the natural host.
One salient result was the determination of the initiation of VP5 expression of IPNV strain VR299. In the past, several reports suggested different AUG codons for initiation of VP5 based on sequence data. Magyar & Dobos (1994) suggested initiation of VP5 expression at position 68, whereas Heppell et al. (1995) assumed that either not all IPNV strains express VP5 or that expression of VP5 is initiated at position 68 or 112 dependent on the strain investigated. Recently, from the sequence of segment A of IPNV strain West Buxton the start for VP5 was proposed to be at position 112 (Yao & Vakharia, 1998) . To unambiguously identify the initiation codon for VP5 in strain VR299 several specific mutations were introduced. The results showed that VP5 expression initiates at position 113 since viable IPNV mutants containing in-frame stop codons downstream from the first AUG at nt 68-70 and upstream of the second in-frame AUG at nt 112 were able to express VP5. However, VP5 expression was abolished in mutants containing substitutions in the second possible initiation codon.
One question remains : how does the ribosome recognize the true start codon of VP5? Initiation of translation should start at the AUG codon nearest to the 5h-end of the mRNA via a scanning mechanism. But certain mechanisms allow escape from this first-AUG rule : (i) reinitiation ; (ii) context-dependent leaky scanning ; (iii) possible direct internal initiation allowing access to AUG codons located close to the 5h-end (Kozak, 1995) ; (iv) transcription of a subgenomic messenger RNA. Analysis of the sequences flanking both possible initiation codons of VP5 revealed a weak context with the optimal sequence for translation initiation in position k3 (pyrimidine instead of purine, see Fig. 2 ) as described by Kozak (1986) . Furthermore, the j4 position of the identified start codon for VP5 also contains a ' weak ' context according to the sequence proposed by Kozak (1986 Kozak ( , 1997 . Thus, the mechanism of translation initiation of VP5 of IPNV will need further investigation.
In summary, we describe here the first VP5 mutant of IPNV obtained using the established reverse genetics system. In addition, we clearly show that the second in-frame AUG codon is responsible for initiation of translation of VP5 and that mutations within VP5 do not influence virus growth in cell culture.
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